StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Jounce Therapeutics (JNCE) PT Lowered to $19 at H.C. Wainwright
May 17, 2018 7:12 AM
H.C. Wainwright lowered its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
JPMorgan Weighs In On Jounce Therapeutics (JNCE) Disappointing First Look at JTX-2011
May 17, 2018 6:32 AM
Wells Fargo Downgrades Jounce Therapeutics (JNCE) to Market Perform Citing Underwhelming ASCO Abstract Data for JTX2011
May 17, 2018 6:31 AM